Login
$BIOA
$5.21 -$0.01 (0.19%) After hours

Company Executives

Officer Age In this role 2025 pay Source
Kristen Fortney Also a director
Chief Executive Officer and President
43 Not stated $2,886,590
Dov Goldstein
Chief Financial Officer
58 Since 2021
5 years
Not reported
Eric Morgen Also a director
Chief Operating Officer
43 Not stated $1,447,240
Paul Rubin
Chief Medical Officer
72 Since 2020
6 years
$1,476,080
Shane Barton
Principal Accounting Officer
Title from the Form 4 dated Jun 29, 2026
Not stated Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
8
serving now
Independent
0 of 2
stated in the proxy; 6 not stated
Average tenure
5.2 years
from year joined
CEO also chairs the board
No
Jean-Pierre Garnier
Director Age On board Independent Committees Other public boards 2025 pay Source
Jean-Pierre Garnier
78 2024
2 years
Not stated
Compensation Committee Nominating and Governance Committee
Carrier Global Corporation Not stated
Kristen Fortney
43 2015
11 years
Not independent None stated None stated Paid as CEO
Eric Morgen
43 2017
9 years
Not independent None stated None stated Not stated
Patrick Enright
64 2024
2 years
Not stated
Audit Committee
Vera Therapeutics, Inc., Jazz Pharmaceuticals plc, Zenas BioPharma, Inc., Veradermics, Incorporated $129,252
James I. Healy
61 2024
2 years
Not stated
Compensation Committee Nominating and Governance Committee · Chair
ArriVent Biopharma, Inc., Rapport Therapeutics, Inc. Not stated
Rekha Hemrajani
56 2021
5 years
Not stated
Audit Committee · Chair Nominating and Governance Committee
ALX Oncology Holdings Inc. $141,752
Vijay Pande
55 2017
9 years
Not stated
Audit Committee
None stated Not stated
Michael Davidson
69 2024
2 years
Not stated
Compensation Committee · Chair Nominating and Governance Committee
Tenax Therapeutics, Inc. $138,752

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 21, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support